Clinical Trial Update: Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing pioglitazone efficacy in patients with inadequately controlled type 2 diabetes on stable triple oral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Takeda | Conditions: Type II Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2018-07-24